Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 043025/0806 | |
| Pages: | 9 |
| | Recorded: | 07/17/2017 | | |
Attorney Dkt #: | 4239-99180-47 THROUGH -50 |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
4
|
|
Patent #:
|
|
Issue Dt:
|
12/13/2011
|
Application #:
|
12398043
|
Filing Dt:
|
03/04/2009
|
Publication #:
|
|
Pub Dt:
|
10/15/2009
| | | | |
Title:
|
DENGUE TETRAVALENT VACCINE CONTAINING A COMMON 30 NUCLEOTIDE DELETION IN THE 3' -UTR OF DENGUE TYPES 1, 2, 3, AND 4 OR ANTIGENIC CHIMERIC DENGUE VIRUSES 1, 2, 3, AND 4
|
|
|
Patent #:
|
|
Issue Dt:
|
10/10/2017
|
Application #:
|
13305639
|
Filing Dt:
|
11/28/2011
|
Publication #:
|
|
Pub Dt:
|
01/10/2013
| | | | |
Title:
|
DENGUE TETRAVALENT VACCINE CONTAINING A COMMON 30 NUCLEOTIDE DELETION IN THE 3'-UTR OF DENGUE TYPES 1, 2, 3, AND 4, OR ANTIGENIC CHIMERIC DENGUE VIRUSES 1, 2, 3, AND 4
|
|
|
Patent #:
|
|
Issue Dt:
|
12/12/2017
|
Application #:
|
13896384
|
Filing Dt:
|
05/17/2013
|
Title:
|
DENGUE TETRAVALENT VACCINE CONTAINING A COMMON 30 NUCLEOTIDE DELETION IN THE 3'-UTR OF DENGUE TYPES 1,2,3, AND 4, OR ANTIGENIC CHIMERIC DENGUE VIRUSES 1,2,3, AND 4
|
|
|
Patent #:
|
|
Issue Dt:
|
12/19/2017
|
Application #:
|
13896388
|
Filing Dt:
|
05/17/2013
|
Title:
|
DENGUE TETRAVALENT VACCINE CONTAINING A COMMON 30 NUCLEOTIDE DELETION IN THE 3'-UTR OF DENGUE TYPES 1,2,3, AND 4, OR ANTIGENIC CHIMERIC DENGUE VIRUSES 1,2,3, AND 4
|
|
Assignee
|
|
|
OFFICE OF TECHNOLOGY TRANSFER, NATIONAL INSTITUTES OF HEALTH |
6011 EXECUTIVE BOULEVARD, SUITE 325, MSC 7660 |
BETHESDA, MARYLAND 20892-7660 |
|
Correspondence name and address
|
|
SUSAN W. GRAF, KLARQUIST SPARKMAN, LLP
|
|
121 SW SALMON STREET, SUITE 1600
|
|
ONE WORLD TRADE CENTER
|
|
PORTLAND, OR 97204
|
Search Results as of:
05/23/2024 10:49 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|